NALIRIFOX as Induction Therapy in LAPC

计划入组 20 人 · 首次发布于 2024 年 6 月 21 日

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

计划入组 30 人 · 首次发布于 2023 年 12 月 1 日

Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study

计划入组 78 人 · 首次发布于 2015 年 5 月 12 日

LASC

LJPC-201

LJPC-1010

Lap USA, Inc.

United States

LAC USC Medical Center

United States

CHONG LAP (H.K.) COMPANY LIMITED

Hong Kong, China

RenovoRx's TIGeR-PaC Trial Enrolls Patients at Northwell Health Cancer Institute

Nab-Paclitaxel Plus S-1 Shows Promise as Induction Therapy for Locally Advanced Pancreatic Cancer

Silexion's LODER Shows Promise in Non-Resectable Pancreatic Cancer